OpGen to Provide Business Update and Financial Results for the First Quarter 2022 on May 12th at 4:30 p.m. Eastern TimeGlobeNewsWire • 04/28/22
OpGen's Subsidiary Curetis and European Investment Bank Plan to Restructure Debt RepaymentGlobeNewsWire • 04/25/22
OpGen's Subsidiary Ares Genetics Commercially Launches New Sequencing and Analysis Services GloballyGlobeNewsWire • 04/20/22
OpGen's subsidiary Ares Genetics provides update on collaboration agreement to drive cutting-edge digital solutions in global fight against antimicrobial resistance (AMR)GlobeNewsWire • 04/06/22
OpGen Announces Interim Analysis Results from Clinical Trial for Unyvero Urinary Tract Infection PanelGlobeNewsWire • 04/05/22
OpGen's (OPGN) CEO Oliver Schacht on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/30/22
OpGen Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business UpdateGlobeNewsWire • 03/29/22
OpGen to Provide Business Update and Financial Results for the Fourth Quarter and Full Year 2021 on March 29th at 4:30 p.m. Eastern TimeGlobeNewsWire • 03/15/22
OpGen Announces Publication of Results from the Acuitas AMR Gene Panel Multicenter Clinical Trial in the Journal of Clinical MicrobiologyGlobeNewsWire • 02/10/22
OpGen to Participate in Edison Group's Global Healthcare “Open House” Virtual Conference from January 25-27th, 2022GlobeNewsWire • 01/18/22
OpGen Announces Preliminary Unaudited Revenue for Fiscal 2021 and Provides Business UpdateGlobeNewsWire • 01/10/22
OpGen subsidiary Ares Genetics announces the strategic expansion of ARESdb proprietary contentsGlobeNewsWire • 12/14/21
OpGen Subsidiary Ares Genetics Announces Strategic Database Access TransactionGlobeNewsWire • 11/30/21
OpGen, Inc. (OPGN) CEO Oliver Schacht on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/12/21
OpGen Reports Third Quarter 2021 Financial Results and Provides Business UpdateGlobeNewsWire • 11/11/21
OpGen, Inc. (OPGN) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 11/04/21
OpGen Announces Special Meeting of Stockholders to Vote on Proposed Increase to Number of Authorized Shares of Common StockGlobeNewsWire • 11/04/21
OpGen to Provide Business Update and Financial Results for the Third Quarter 2021 on November 11th at 4:30 p.m. Eastern TimeGlobeNewsWire • 10/28/21